ISIN | LU2207278669 |
---|---|
Valor Number | 114371863 |
Bloomberg Global ID | |
Fund Name | Kieger Impact Healthcare Fund Class R USD Accumulating |
Fund Provider |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Phone: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
Fund Provider | Kieger AG |
Representative in Switzerland |
ACOLIN Fund Services AG Zürich Phone: +41 44 396 96 96 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related companies or issuers worldwide (including Emerging Markets) with a focus on issuers that contribute to the realisation of the healthcare related United Nations Sustainable Development Goals ("SDGs"). No guarantee can be given that the investment objective will be achieved. |
Peculiarities |
Current Price * | 88.53 USD | 19.06.2025 |
---|---|---|
Previous Price * | 88.74 USD | 18.06.2025 |
52 Week High * | 97.97 USD | 16.07.2024 |
52 Week Low * | 81.01 USD | 08.04.2025 |
NAV * | 88.53 USD | 19.06.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 76,213,175 | |
Unit/Share Assets *** | 1,757 | |
Trading Information SIX |
YTD Performance | +2.04% |
31.12.2024 - 19.06.2025
31.12.2024 19.06.2025 |
---|---|---|
YTD Performance (in CHF) | -8.18% |
31.12.2024 - 19.06.2025
31.12.2024 19.06.2025 |
1 month | -0.25% |
19.05.2025 - 19.06.2025
19.05.2025 19.06.2025 |
3 months | -0.96% |
19.03.2025 - 19.06.2025
19.03.2025 19.06.2025 |
6 months | +2.34% |
19.12.2024 - 19.06.2025
19.12.2024 19.06.2025 |
1 year | -3.89% |
19.06.2024 - 19.06.2025
19.06.2024 19.06.2025 |
2 years | -11.47% |
06.07.2023 - 19.06.2025
06.07.2023 19.06.2025 |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Abbott Laboratories | 4.14% | |
---|---|---|
Revvity Inc | 3.89% | |
Centene Corp | 3.88% | |
Humana Inc | 3.81% | |
ResMed Inc | 3.77% | |
Hologic Inc | 3.76% | |
Hypera SA | 3.76% | |
Aspen Pharmacare Holdings Ltd | 3.72% | |
Sanofi SA | 3.72% | |
Sandoz Group AG Registered Shares | 3.70% | |
Last data update | 31.03.2025 |
TER *** | 2.22% |
---|---|
TER date *** | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 2.00% |
Ongoing Charges *** | 2.22% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |